Equine Protozoal Myeloencephalitis: Treatment, Prognosis, and Prevention

Clinical Techniques in Equine Practice

Volumn 5, Issue 1, 2006, Pages 9-16

  MacKay, Robert J ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

equine protozoal myeloencephalitis; nitazoxanide; ponazuril; pyrimethamine; Sarcocystis neurona; sulfonamide; toltrazuril; treatment

Indexed keywords

EQUIDAE; EQUUS CABALLUS; SARCOCYSTIS NEURONA;

EID: 33646096961     PISSN: 15347516     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ctep.2006.01.003     Document Type: Article

References (48)

1. Cusick P.K., Sells D.M., Hamilton D.P., et al. Toxoplasmosis in two horses. J Am Vet Med Assoc 164 (1974) 77-80
2. Beech J. Equine protozoan encephalomyelitis. Vet Med Small Anim Clin 69 (1974) 1562-1566
3. Dubey J.P., Davis G.W., Koestner A., et al. Equine encephalomyelitis due to a protozoan parasite resembling Toxoplasma gondii. J Am Vet Med Assoc 165 (1974) 249-255
4. Mayhew I.G., de Lahunta A., Whitlock R.H., et al. Equine protozoal myeloencephalitis. AAEP Proceedings 22 (1976) 107-122
5. van Miert A.S. The sulfonamide-diaminopyrimidine story. J Vet Pharmacol Ther 17 (1994) 309-316
6. Harder A., and Haberkorn A. Possible mode of action of toltrazuril. studies on two Eimeria species and mammalian and Ascaris suum enzymes. Parasitol Res 76 (1989) 8-12
7. Mitchell S.M., Zajac A.M., Davis W.L., et al. The effects of ponazuril on development of apicomplexans in vitro. J Eukaryot Microbiol 52 (2005) 231-235
8. Sisson G., Goodwin A., Raudonikiene A., et al. Enzymes associated with reductive activation and action of nitazoxanide, nitrofurans, and metronidazole in Helicobacter pylori. Antimicrob Agents Chemother 46 (2002) 2116-2123
9. Esposito M., Stettler R., Moores S.L., et al. In vitro efficacies of nitazoxanide and other thiazolides against Neospora caninum tachyzoites reveal antiparasitic activity independent of the nitro group. Antimicrob Agents Chemother 49 (2005) 3715-3723
10. Brown M.P., Gronwall R., and Castro L. Pharmacokinetics and body fluid and endometrial concentrations of trimethoprim-sulfamethoxazole in mares. Am J Vet Res 49 (1988) 918-922
11. Green S.L., Mayhew I.G., Brown M.P., et al. Concentrations of trimethoprim and sulfamethoxazole in cerebrospinal fluid and serum in mares with and without a dimethyl sulfoxide pretreatment. Can J Vet Res 54 (1990) 215-222
12. Gustafsson A., Baverud V., Franklin A., et al. Repeated administration of trimethoprim/sulfadiazine in the horse. pharmacokinetics, plasma protein binding and influence on the intestinal microflora. J Vet Pharmacol Ther 22 (1999) 20-26
13. Clarke C.R., MacAllister C.G., Burrows G.E., et al. Pharmacokinetics, penetration into cerebrospinal fluid, and hematologic effects after multiple oral administrations of pyrimethamine to horses. Am J Vet Res 53 (1992) 2296-2299
14. Bayer Corporation. Freedom of information summary. NADA 141-188. Marquis™ (15% w/w ponazuril) antiprotozoal oral paste for treatment of equine protozoal myeloencephalitis caused by Sarcocystis neurona. 1-18, 2001
15. Furr M., Kennedy T., MacKay R., et al. Efficacy of ponazuril 15% oral paste as a treatment for equine protozoal myeloencephalitis. Vet Ther 2 (2001) 215-222
16. Furr M., and Kennedy T. Cerebrospinal fluid and blood concentrations of toltrazuril 5% suspension in the horse after oral dosing. Vet Ther 1 (2000) 125-132
17. IDEXX Pharmaceuticals. Freedom of information summary. NADA 141-178. NAVIGATOR (32% nitazoxanide). Antiprotozoal oral paste for the treatment of horses with equine protozoal myeloencephalitis (EPM) caused by Sarcocystis neurona. 2003
18. Dirikolu L., Lehner F., Nattrass C., et al. Diclazuril in the horse. its identification and detection and preliminary pharmacokinetics. J Vet Pharmacol Ther 22 (1999) 374-379
19. Schering-Plough Animal Health. Freedom of information summary (draft). PROTAZIL (1.56% diclazuril) Antiprotozoal Pellets for the treatment of horses with equine protozoal myeloencephalitis (EPM) caused by Sarcocystis neurona. 2005
20. Clarke C.R., Burrows G.E., MacAllister C.G., et al. Pharmacokinetics of intravenously and orally administered pyrimethamine in horses. Am J Vet Res 53 (1992) 2292-2295
21. van Duijkeren E., Vulto A.G., Sloet van Oldruitenborgh-Oosterbaan M.M., et al. Pharmacokinetics of trimethoprim/sulphachlorpyridazine in horses after oral, nasogastric and intravenous administration. J Vet Pharmacol Ther 18 (1995) 47-53
22. Dubey J.P., Davis S.W., Speer C.A., et al. Sarcocystis neurona n. sp. (Protozoa: Apicomplexa), the etiologic agent of equine protozoal myeloencephalitis. J Parasitol 77 (1991) 212-218
23. Lindsay D.S., Dubey J.P., and Kennedy T.J. Determination of the activity of ponazuril against Sarcocystis neurona in cell cultures. Vet Parasitol 92 (2000) 165-169
24. Lindsay D.S., and Dubey J.P. Determination of the activity of pyrimethamine, trimethoprim, sulfonamides, and combinations of pyrimethamine and sulfonamides against Sarcocystis neurona in cell cultures. Vet Parasitol 82 (1999) 205-210
25. 3H-uracil incorporation by Sarcocystis neurona to determine efficacy of anti-protozoal agents. Vet Parasitol 95 (2001) 241-249
26. Lindsay D.S., and Dubey J.P. Determination of the activity of diclazuril against Sarcocystis neurona and Sarcocystis falcatula in cell cultures. J Parasitol 86 (2000) 164-166
27. Lindsay D.S., ZY, and Dubey J.P. Determination of the activity of nitazoxanide against Sarcocystis neurona in cell cultures. Proceedings of the American Association of Veterinary Parasitologists, 43rd Annual Meeting 44 (1998)
28. Gargala G., Ballet J.J., and Favannec L. In vitro efficacy of nitazoxanide glucuronide against Sarcocystis neurona. Unpublished report (2001) (courtesy of Dr. R. Keene, IDEXX Pharmaceuticals, 2005)
29. Fritz D.L., and Dubey J.P. Pathology of Sarcocystis neurona in interferon-gamma gene knockout mice. Vet Pathol 39 (2002) 137-140
30. Dubey J.P., Fritz D., Lindsay D.S., et al. Diclazuril preventive therapy of gamma interferon knockout mice fed Sarcocystis neurona sporocysts. Vet Parasitol 94 (2001) 257-264
31. Franklin R.P., MacKay R.J., Gillis K.D., et al. Effect of a single dose of ponazuril on neural infection and clinical disease in Sarcocystis neurona-challenged interferon-gamma knockout mice. Vet Parasitol 114 (2003) 123-130
32. Lindsay D.S., Rippey N.S., and Blagburn B.L. Treatment of acute Toxoplasma gondii infections in mice with diclazuril or a combination of diclazuril and pyrimethamine. J Parasitol 81 (1995) 315-318
33. MacKay RJ, Tanhauser ST, Gillis KD, Mayhew IG, Kennedy TJ: Effect of intermittent ponazuril on experimental Sarcocystis neurona infection of horses. Vet Parasitol, Submitted for publication
34. Dubey J.P., Saville W.J., Stanek J.F., et al. Sarcocystis neurona infections in raccoons (Procyon lotor). evidence for natural infection with sarcocysts, transmission of infection to opossums (Didelphis virginiana), and experimental induction of neurologic disease in raccoons. Vet Parasitol 100 (2001) 117-129
35. Animal Health Pharmaceuticals. Freedom of information summary. NADA 141-240. REBALANCE Antiprotozoal oral suspension (sulfadiazine and pyrimethamine) for the treatment of horses with equine protozoal myeloencephalitis (EPM) caused by Sarcocystis neurona. 1, 2004
36. Hundley B., Maclin R., and US Patent application. Compositions and methods for prevention and treatment of protozoal disease. New Ace Research Company 20 (2001) 1-13 [6,465,460 B1] Kentucky
37. Fenger C.K. Treatment of equine protozoal myeloencephalitis. Compend Cont Ed Pract Vet 20 (1998) 1154-1157
38. Podzamczer D., Miro J.M., Ferrer E., et al. Thrice-weekly sulfadiazine-pyrimethamine for maintenance therapy of toxoplasmic encephalitis in HIV-infected patients. Spanish Toxoplasmosis Study Group. Eur J Clin Microbiol Infect Dis 19 (2000) 89-95
39. Brendemuehl J.P., Waldridge B.M., and Bridges E.R. Effects of sulfadiazine and pyrimethamine and concurrent folic acid supplementation on pregnancy and embryonic loss rates in mares. AAEP Proc 44 (1998) 142-143
40. Bedford S.J., and McDonnell S.M. Measurements of reproductive function in stallions treated with trimethoprim-sulfamethoxazole and pyrimethamine. J Am Vet Med Assoc 215 (1999) 1317-1319
41. Toribio R.E., Bain F.T., Mrad D.R., et al. Congenital defects in newborn foals of mares treated for equine protozoal myeloencephalitis during pregnancy. J Am Vet Med Assoc 212 (1998) 697-701
42. Piercy R.J., Hinchcliff K.W., and Reed S.M. Folate deficiency during treatment with orally administered folic acid, sulphadiazine and pyrimethamine in a horse with suspected equine protozoal myeloencephalitis (EPM). Equine Vet J 34 (2002) 311-316
43. Chung M.K., Han S.S., and Roh J.K. Synergistic embryotoxicity of combination pyrimethamine and folic acid in rats. Reprod Toxicol 7 (1993) 463-468
44. Kennedy T. Effect of ponazuril on pregnancy. Unpublished report (2000)
45. Fort Dodge Animal Health. Equine protozoal myeloencephalitis (2005). http://www.epmvaccine.com/ Available at:http://www.epmvaccine.com/. Accessed
46. Witonsky S., Morrow J.K., Leger C., et al. Sarcocystis neurona-specific immunoglobulin G in the serum and cerebrospinal fluid of horses administered S neurona vaccine. J Vet Intern Med 18 (2004) 98-103
47. Marsh A.E., Lakritz J., Johnson P.J., et al. Evaluation of immune responses in horses in horses immunized using a killed Sarcocystis neurona vaccine. Vet Ther 5 (2004) 34-42
48. Dubey J.P., Saville W.J., Sreekumar C., et al. Effects of high temperature and disinfectants on the viability of Sarcocystis neurona sporocysts. J Parasitol 88 (2002) 1252-1254